Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study
- 22 September 2025
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (1)
Abstract
Objectives: This study aimed to identify predictors of clinical inertia in SLE management and to evaluate its impact on clinical outcomes. Methods: A historical cohort study was conducted using data from the multicentre LUNA cohort in Japan. The 365 patients with active disease 1 year before baseline (SLE Disease Activity Index score >4 or active gastrointestinal lesions or haemolytic anaemia) were classified by baseline disease activity and treatment intensification status over 1 year into non-intensification (n = 247) vs intensification (n = 118) groups. Furthermore, the clinical inertia group (n = 116), defined as sustained active disease without intensification, was compared with the non-clinical inertia group (n = 249), which comprised all other patients. Regression analyses assessed predictors and outcomes, including damage accrual, disease activity, quality of life (QoL) and patient satisfaction. Results: Non-intensification was associated with larger increases in glucocorticoid-related damage, while clinical inertia was linked to greater increases in overall and glucocorticoid-related damage. Non-intensification and clinical inertia correlated with a tendency towards reduced QoL across several domains. HCQ use and fewer concomitant immunosuppressants predicted non-intensification of treatment, whereas female sex and greater damage accrual predicted clinical inertia; older age showed similar but non-significant trends for both outcomes. Conclusion: Because clinical inertia can drive damage accrual and QoL deterioration, avoiding clinical inertia is a therapeutic priority. Regular reassessment of treatment strategy is essential for older patients, women and those with greater damage. Proactive tailoring of treatment to individual risk profiles can arrest clinical inertia and improve long-term outcomes.Keywords
This publication has 29 references indexed in Scilit:
- Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early DamageArthritis Care & Research, 2019
- Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin MonotherapyClinical Therapeutics, 2017
- Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitusDiabetes Research and Clinical Practice, 2014
- Optimizing outcome in SLE: treating-to-target and definition of treatment goalsAutoimmunity Reviews, 2014
- Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activityJournal of Crohn's and Colitis, 2011
- Development and validation of a disease‐specific health‐related quality of life measure, the LupusQol, for adults with systemic lupus erythematosusArthritis Care & Research, 2007
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosusArthritis & Rheumatism, 1996
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- The medical interview satisfaction scale: Development of a scale to measure patient perceptions of physician behaviorJournal of Behavioral Medicine, 1978